GeneOne Life Science, Inc. (011000.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 33.46B |
| Enterprise Value | 65.08B |
| P/E Ratio | -0.23 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 2.69 |
| Price/Book Ratio | 0.91 |
| Enterprise/Revenue | 4.29 |
| Enterprise/EBITDA | -2.94 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -2.29 |
| Operating Margin | -1.98 |
AD
Management Effectiveness
| Return On Assets | -0.31 |
| Return On Equity | -0.77 |
Income Statement
| Revenue | 23.93B |
| Revenue/Share | 1,036.84 |
| Gross Profit | -21.43B |
| EBITDA | -28.6B |
| Net Income | -47.66B |
| Diluted EPS | -13,951 |
Balance Sheet
| Total Cash | 6.82B |
| Total Cash/Share | 392.84 |
| Total Debt | 34.15B |
| Total Debt/Equity | 0.67 |
| Current Ratio | 0.46 |
| Book Value Per Share | 2,945.27 |
Price History
| 52-Week Change | -76.53 |
| 52-Week High | 2,685 |
| 52-Week Low | 520 |
| Moving Average 50 Days | 1,015.42 |
| Moving Average 200 Days | 1,593.4 |
Statistics
| Average Volume | 7.64M |
| Shares Outstanding | 18.13M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
| Last Split Date | June 25, 2026 |
AD
